Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan 18:32:102111.
doi: 10.1016/j.pmedr.2023.102111. eCollection 2023 Apr.

Barriers to and facilitators of hormonal and long-acting reversible contraception access and use in the US among reproductive-aged women who use opioids: A scoping review

Affiliations

Barriers to and facilitators of hormonal and long-acting reversible contraception access and use in the US among reproductive-aged women who use opioids: A scoping review

Elizabeth Charron et al. Prev Med Rep. .

Abstract

Existing research has found that women who use opioids (WWUO) experience challenges to hormonal and long-acting reversible contraception (HC-LARC) access and use. Facilitators of such use are unclear. We conducted a scoping review to comprehensively map the literature on barriers to and facilitators of HC-LARC access and use in the United States among reproductive-aged WWUO. In accordance with the JBI Manual of Evidence Synthesis, we conducted literature searches for empirical articles published from 1990 to 2021. Independent reviewers screened references, first by titles and abstracts, then by full-text, and charted data of eligible articles. We coded and organized HC-LARC barriers and facilitators according to a four-level social-ecological model (SEM) and categorized findings within each SEM level into domains. We screened 4,617 records, of which 28 articles focusing on HC-LARC (n = 18), LARC only (n = 6), or testing an intervention to increase HC-LARC uptake (n = 4) met inclusion criteria. We identified 13 domains of barriers and 11 domains of facilitators across four SEM levels (individual, relationship, community, societal). The most frequently cited barriers and facilitators were methods characteristics, partner and provider relations, transportation, healthcare availability and accessibility, cost, insurance, and stigma. Future studies would benefit from recruiting participants and collecting data in community settings, targeting more diverse populations, and identifying neighborhood, social, and policy barriers and facilitators. Reducing barriers and improving equity in HC-LARC access and use among WWUO is a complex, multifaceted issue that will require targeting factors simultaneously at multiple levels of the social-ecological hierarchy to effect change.

Keywords: Contraceptive access; Hormonal contraception; Long-acting reversible contraception; Opioid use; Opioid use disorder; Opioids; Scoping review.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Social-ecological model framework and definitions.
Fig. 2
Fig. 2
Author-identified domains of barriers to and facilitators of hormonal and long-acting reversible contraception access and use among women who use opioids, by social-ecological model levels.

Similar articles

Cited by

References

    1. Aiken A.R., Borrero S., Callegari L.S., Dehlendorf C. Rethinking the pregnancy planning paradigm: unintended conceptions or unrepresentative concepts? Perspect. Sex Reprod. Health. 2016;48:147–151. - PMC - PubMed
    1. Alvidrez J., Castille D., Laude-Sharp M., Rosario A., Tabor D. The national institute on minority health and health disparities research framework. Am. J. Public Health. 2019;109:S16–S20. - PMC - PubMed
    1. Arksey H., O'Malley L. Taylor and Francis Group Ltd; 2005. Scoping studies: Towards a Methodological Framework, International Journal of Social Research Methodology: Theory and Practice; pp. 19–32.
    1. Armstrong K.A., Kenen R., Samost L. Barriers to family planning services among patients in drug treatment programs. Fam. Plann. Perspect. 1991;23(264–6):70. - PubMed
    1. Asker C., Stokes-Lampard H., Beavan J., Wilson S. What is it about intrauterine devices that women find unacceptable? Factors that make women non-users: a qualitative study. J. Fam. Plann. Reprod. Health Care. 2006;32:89–94. - PubMed

Publication types

LinkOut - more resources